Clinical Trials Directory

Trials / Unknown

UnknownNCT03645473

Evaluation of Device Settings for Airway Clearance Using The Monarch Airway Clearance System

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Hill-Rom · Industry
Sex
All
Age
15 Years
Healthy volunteers
Not accepted

Summary

The study will be an open label laboratory study with all subjects receiving HFCWO with The Monarch® System Objective: Assess device settings and to identify frequency/pressure (intensity) combinations that produce high airflow and oscillating volume Methodology: Subjects will receive HFCWO using The Monarch® System at multiple frequency / intensity combinations on a single visit day. Frequency / intensity combinations will be evaluated to determine which settings produce highest airflow and highest oscillating volume.

Detailed description

The study will be an open-label, laboratory study. All enrolled subjects will receive HFCWO therapy with the Monarch® system. The study will be conducted at one (1) site in the US. The study will evaluate oscillating airflow and oscillating volume induced during therapy with the Monarch® system. Subjects will also rate the comfort of the therapy. Patients with cystic fibrosis (CF) who meet all of the inclusion criteria and none of the exclusion criteria will be enrolled in the study. Therapy with the Monarch® system will be delivered using multiple frequency/intensity combination settings. The order of settings will be randomized for each study subject. During therapy oscillating flow and volume measurements will be obtained for each frequency/intensity combination. Following each frequency/intensity combination, subjects will respond to a subjective assessment of the comfort of the therapy by rating the comfort on a visual analogue scale (VAS).

Conditions

Interventions

TypeNameDescription
DEVICEMonarch Airway Clearance SystemHFCWO Airway Clearance Device

Timeline

Start date
2019-01-24
Primary completion
2019-03-12
Completion
2019-04-12
First posted
2018-08-24
Last updated
2018-12-31

Source: ClinicalTrials.gov record NCT03645473. Inclusion in this directory is not an endorsement.